• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    More On CMXHF

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    CSL Ltd. (CMXHF)

    -Other OTC
    68.24 Up 3.00(4.59%) Jul 2, 12:12PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    CSL Ltd.
    45 Poplar Road
    Parkville, VIC 3052
    Australia - Map
    Phone: 61 3 9389 1911
    Fax: 61 3 9389 1434
    Website: http://www.csl.com.au

    Details 
    Index Membership:N/A
    Sector:N/A
    Industry:N/A
    Full Time Employees:12,196

    Business Summary 

    CSL Limited is engaged in the research, development, manufacture, marketing, and distribution of biopharmaceutical and allied products in Australia, the United States, Switzerland, Germany, and internationally. The company operates through CSL Behring, bioCSL, and CSL Intellectual Property segments. The CSL Behring segment manufactures, markets, and develops plasma products and recombinants that are used to treat coagulation disorders, including hemophilia and von Willebrand disease, primary immune deficiencies, hereditary angioedema and inherited respiratory disease, and neurological disorders, cardiac surgery, organ transplantation, and burn treatment, as well as to prevent hemolytic diseases in the newborn. The bioCSL segment manufactures and distributes non-plasma biotherapeutic products, including vaccines to protect against viral and bacterial diseases; pharmaceuticals to treat a range of human medical conditions; diagnostic products to determine compatibility of donor-recipient blood in transfusion settings; and antivenoms to treat victims of venomous snake and spider bites. The CSL Intellectual Property segment is engaged in the commercialization of intellectual property. In addition, the company markets various vaccines and antivenoms, as well as a range of pharmaceutical products supplied by other manufacturers. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on CSL Ltd.

    Key Executives 
     PayExercised
    Mr. Paul R. Perreault BA Psychology, 58
    Chief Exec. Officer, Managing Director, Exec. Director and Member of Innovation & Devel. Committee
    2.41M0.00
    Mr. Gordon Naylor Mba, Beng (Hons), Dipcompsc, 52
    Chief Financial Officer
    1.69M0.00
    Dr. Andrew Cuthbertson BMedSci, MBBS, Ph.D., 60
    Chief Scientific officer and Director of R&D
    1.40M0.00
    Mr. Gregory Boss J.D., BS(Hon), 54
    Exec. VP of Legal, Group Gen. Counsel, Exec. VP of CSL Behring and Gen. Counsel of CSL Behring
    1.14M0.00
    Ms. Mary Sontrop B.Appsc, MBA, 58
    Exec. VP of Manufacturing Operations & Planning
    1.73M0.00
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.